Windlas Biotech Ltd.

NSE: WINDLAS | BSE: 543329 | ISIN: INE0H5O01029 | Industry: Pharmaceuticals
| Mid-range Performer
892.3000 -2.80 (-0.31%)
NSE Jun 27, 2025 15:31 PM
Volume: 44,810
 

892.30
-0.31%
Prabhudas Lilladhar
experience in manufacturing (solid/ liquid) multiple dosage offers a comprehensive range of CDMO services in India. Over time Windlas evolved and 6) strong financial performance with experienced management. It owns...
Windlas Biotech Ltd. has gained 28.64% in the last 1 Year
More from Windlas Biotech Ltd.
Recommended